Skip to main content
Conor Liston, MD, Psychiatry, New York, NY

Conor Michael Liston MD


Physician

Request Appointment
  • 525 E 68th St # 140Department Of PsychiatryNew York, NY 10065

  • Book by Phone+1(734) 304-7181

  • Fax+1 212-746-8886

Overview of  Dr. Liston

Dr. Conor Liston is a psychiatrist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from Weill Cornell Medicine and has been in practice 18 years. He is one of 963 doctors at New York-Presbyterian Hospital who specialize in Psychiatry. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 2008 - 2012
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2010 - 2028

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • This AI Tool Helps Healthcare Workers Look After Their Mental HealthSeptember 2020

Press Mentions

  • Reverse Engineering Ketamine’s Effects May Lead to New Antidepressants
    Reverse Engineering Ketamine’s Effects May Lead to New AntidepressantsMay 1st, 2026
  • Grant Supports Studies to Improve and Personalize Bipolar Care
    Grant Supports Studies to Improve and Personalize Bipolar CareOctober 28th, 2025
  • Brain Network Twice as Large in Depressed Individuals
    Brain Network Twice as Large in Depressed IndividualsSeptember 6th, 2024

Grant Support

  • AR² - Autism Replication, Validation, and Reproducibility CenterWEILL MEDICAL COLL OF CORNELL UNIV2025–2028
  • Neuromodulatory control of prefrontal circuit function and reward-seekingWEILL MEDICAL COLL OF CORNELL UNIV2018–2028
  • Biomarker-Guided Antidepressant Selection for Treatment-Resistant DepressionWEILL MEDICAL COLL OF CORNELL UNIV2024–2026
  • Efficacy of biomarker-guided rTMS for treatment resistant depressionWEILL MEDICAL COLL OF CORNELL UNIV2019–2026
  • Development of opioid and ketamine probes for in vivo photopharmacology (Diversity Supplement)UNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: